Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "ORPHAN DRUG|Designated|Treatment of fragile X syndrome" in comments (approximate match)

Showing 11 - 18 of 18 results

First page
Previous page
2
Next page disabled
Next page disabled

BRYOSTATIN 1

37O2X55Y9E

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

FLINDOKALNER

J57O328W4W

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

METADOXINE

EJQ7M98H5J

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

IBUDILAST

M0TTH61XC5

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

.ALPHA.-TOCOPHEROL

H4N855PNZ1

Status:

Other

Class:

MIXTURE

GABOXADOL

K1M5RVL18S

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

FENOBAM HYDROCHLORIDE

18X2C0C12Z

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

LISURIDE MALEATE

UV1635N8XW

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of BRYOSTATIN 1

ABSOLUTE

Structure of FLINDOKALNER

ABSOLUTE

Structure of METADOXINE

ABSOLUTE

Structure of IBUDILAST

ACHIRAL

Mixture

.ALPHA.-TOCOPHEROL

Structure of GABOXADOL

ACHIRAL

Structure of FENOBAM HYDROCHLORIDE

ACHIRAL

FENOBAM HYDROCHLORIDE

Structure of LISURIDE MALEATE

ABSOLUTE

LISURIDE MALEATE

Showing 11 - 18 of 18 results

First page
Previous page
2
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1